190 related articles for article (PubMed ID: 14529622)
1. Binders based on dimerised immunoglobulin VH domains.
Sepúlveda J; Jin H; Sblattero D; Bradbury A; Burrone OR
J Mol Biol; 2003 Oct; 333(2):355-65. PubMed ID: 14529622
[TBL] [Abstract][Full Text] [Related]
2. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
3. The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3.
Li Y; Spellerberg MB; Stevenson FK; Capra JD; Potter KN
J Mol Biol; 1996 Mar; 256(3):577-89. PubMed ID: 8604140
[TBL] [Abstract][Full Text] [Related]
4. Mutation of a single conserved residue in VH complementarity-determining region 2 results in a severe Ig secretion defect.
Wiens GD; Lekkerkerker A; Veltman I; Rittenberg MB
J Immunol; 2001 Aug; 167(4):2179-86. PubMed ID: 11490003
[TBL] [Abstract][Full Text] [Related]
5. Structural correlates of immunoglobulin diversity.
Potter M
Surv Immunol Res; 1983; 2(1):27-42. PubMed ID: 6417753
[TBL] [Abstract][Full Text] [Related]
6. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
7. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
8. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
Kabat EA; Wu TT
J Immunol; 1991 Sep; 147(5):1709-19. PubMed ID: 1908882
[TBL] [Abstract][Full Text] [Related]
9. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
Polymenis M; Stollar BD
J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
[TBL] [Abstract][Full Text] [Related]
10. Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes.
Kato M; Hanyu Y
J Immunol Methods; 2013 Oct; 396(1-2):15-22. PubMed ID: 23916870
[TBL] [Abstract][Full Text] [Related]
11. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
Khalifa MB; Weidenhaupt M; Choulier L; Chatellier J; Rauffer-Bruyère N; Altschuh D; Vernet T
J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
[TBL] [Abstract][Full Text] [Related]
12. Selection and characterisation of binders based on homodimerisation of immunoglobulin V(H) domains.
Jin H; Sepúlveda J; Burrone OR
FEBS Lett; 2003 Nov; 554(3):323-9. PubMed ID: 14623088
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
Arndt KM; Müller KM; Plückthun A
Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
[TBL] [Abstract][Full Text] [Related]
14. Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody.
Shanehbandi D; Majidi J; Kazemi T; Baradaran B; Aghebati-Maleki L
Hum Antibodies; 2017; 26(1):1-6. PubMed ID: 28269762
[TBL] [Abstract][Full Text] [Related]
15. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
16. Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions.
Yamauchi S; Kobashigawa Y; Fukuda N; Teramoto M; Toyota Y; Liu C; Ikeguchi Y; Sato T; Sato Y; Kimura H; Masuda T; Ohtsuki S; Noi K; Ogura T; Morioka H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31323851
[TBL] [Abstract][Full Text] [Related]
17. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
[TBL] [Abstract][Full Text] [Related]
18. V
Fernández-Quintero ML; Hoerschinger VJ; Lamp LM; Bujotzek A; Georges G; Liedl KR
Proteins; 2020 Jul; 88(7):830-839. PubMed ID: 31904133
[TBL] [Abstract][Full Text] [Related]
19. Specific recognition of a dsDNA sequence motif by an immunoglobulin VH homodimer.
Jin H; Sepúlveda J; Burrone OR
Protein Sci; 2004 Dec; 13(12):3222-9. PubMed ID: 15557264
[TBL] [Abstract][Full Text] [Related]
20. A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells.
Choi DK; Bae J; Shin SM; Shin JY; Kim S; Kim YS
MAbs; 2014; 6(6):1402-14. PubMed ID: 25484049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
